Intellectual Property Rights and Access to Innovation: Evidence from Trips

@article{Kyle2014IntellectualPR,
  title={Intellectual Property Rights and Access to Innovation: Evidence from Trips},
  author={Margaret Kyle and Yi Qian},
  journal={Kauffman: Large Research Projects (Topic)},
  year={2014}
}
  • M. Kyle, Yi Qian
  • Published 2014
  • Economics
  • Kauffman: Large Research Projects (Topic)
We examine the effect of pharmaceutical patent protection on the speed of drug launch, price, and quantity in 60 countries from 2000-2013. The World Trade Organization required its member countries to implement a minimum level of patent protection within a specified time period as part of the TRIPS Agreement. However, members retained the right to impose price controls and to issue compulsory licenses under certain conditions. These countervailing policies were intended to reduce the potential… Expand
Do Patents Work? Thickets, Trolls and Antibiotic Resistance
This paper connects ideas from recent literature on the economics of intellectual property (IP) to address the question: Did the strengthening and broadening of IP rights from important patent policyExpand
Patent protection in developing countries and global welfare: WTO obligations versus flexibilities
Abstract This paper develops a North-South model to evaluate the South's incentive for patent protection when a Northern firm's investment in quality-enhancing research and development (R&D) isExpand
Patents, trade and medicines: past, present and future
Abstract This article analyzes the spread of intellectual property in trade agreements. We explain how the integration of intellectual property with international trade rules led to the globalizationExpand
Trade, Intellectual Property Rights, and the World Trade Organization
This paper surveys the literature on international trade and the protection of intellectual property rights (IPRs) in the global economy. The discussion is organized around the major questions in theExpand
The hidden cost of low prices: limited access to new drugs in India.
TLDR
It is concluded that modest patent and regulatory reform could bring the faster availability of a wider range of new drugs in India with limited impact on prices--a trade-off that merits greater policy attention. Expand
The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India
In 2005, as the result of a World Trade Organization mandate, India began to implement product patents for pharmaceuticals that were compliant with the 1995 Trade-Related Aspects of IntellectualExpand
Patents, Innovation, and Development
I survey some recent research on the role of patents in encouraging innovation and growth in developing economies, beginning with a brief history of international patent systems and facts about theExpand
Does Regulation Drive International Research Cooperation? Evidence from the Pharmaceutical Sector
To what extent is an increased stringency of the Intellectual Property Rights (IPR) system apt to stimulate research cooperation between developed and emerging economies? To address this question, weExpand
Does Regulation Drive International Research Cooperation? Evidence from the Pharmaceutical Sector
To what extent is an increased stringency of the Intellectual Property Rights (IPR) system apt to stimulate research cooperation between developed and emerging economies? To address this question, weExpand
Intellectual Property Rights and Innovation: Evidence from Health Care Markets
A long theoretical literature has analyzed optimal patent policy design, yet there is very little empirical evidence on a key parameter needed to apply these models in practice: the relationshipExpand
...
1
2
3
4
...

References

SHOWING 1-10 OF 38 REFERENCES
Do Patents Matter?: Empirical Evidence after GATT
Since the late 1980s the global intellectual property rights (IPR) system has been strengthening dramatically as much of the developing world introduces patent protection for new drug products. ThisExpand
Investments in Pharmaceuticals Before and After TRIPS
Abstract The TRIPS Agreement, which specifies minimum levels of intellectual property protection for countries in the WTO, has increased levels of patent protection around the world. Using variationExpand
Diffusion of New Drugs in the Post-TRIPS Era
Abstract We examine the international diffusion of new drugs under the post-TRIPS intellectual property rights regime. Even after controlling for drug characteristics and variation in national healthExpand
The hidden cost of low prices: limited access to new drugs in India.
TLDR
It is concluded that modest patent and regulatory reform could bring the faster availability of a wider range of new drugs in India with limited impact on prices--a trade-off that merits greater policy attention. Expand
The Role of Firm Characteristics in Pharmaceutical Product Launches
This paper examines the determinants of new pharmaceutical launches since 1980 in the G7 nations using discrete-time hazard models. Despite the obvious incentive to amortize the large sunk costs ofExpand
Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India
TLDR
It is estimated that the withdrawal of all domestic products in the fluoroquinolones subsegment of the systemic anti-bacterials segment of the Indian pharmaceuticals market is associated with substantial welfare losses to the Indian economy, even in the presence of price regulation. Expand
The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India
In 2005, as the result of a World Trade Organization mandate, India began to implement product patents for pharmaceuticals that were compliant with the 1995 Trade-Related Aspects of IntellectualExpand
How trade-related are intellectual property rights?
Abstract There is little empirical evidence about whether differing international levels of patent protection influence trade flows. If a nation strengthens its patent laws it could experience higherExpand
DETERMINANTS OF PATENT RIGHTS : A CROSS-NATIONAL STUDY
Abstract This paper presents an index of patent rights for 110 countries for the period 1960–1990. The index is used to examine what factors or characteristics of economies determine how stronglyExpand
The Impact of Stronger Property Rights in Pharmaceuticals on Innovation in Developed and Developing Countries
We use dynamic panel data regressions to investigate whether the strength of a country’s patent protection for pharmaceuticals is associated with more pharmaceutical patenting by its residents andExpand
...
1
2
3
4
...